Imagine MedEd that thinks, adapts, and delivers unprecedented insights. Better yet, experience if for yourself in our ...

Gilead Sciences’ twice-yearly injectable pre-exposure prophylaxis (PrEP) drug has been approved by the US Food and Drug ...

The US Food and Drug Administration (FDA) has approved CSL’s Andembry (garadacimab-gxii) to prevent attacks of hereditary ...

Galderma’s Nemluvio (nemolizumab) has demonstrated sustained and clinically meaningful improvements in the key signs and ...

The use of AI in pharma can expedite drug development and manufacturing, enabling novel medicines to get to underserved ...

That’s why empowering local voices within global teams is mission critical. It’s not just about having someone in the seat; ...

Medscape Education is proud to present 11 publications at the American Diabetes Association 85th Scientific Sessions, taking place June 20–23 in Chicago.

Eli Lilly has announced that it will be acquiring Verve Therapeutics in a deal worth approximately $1.3bn, marking a ...

The US Food and Drug Administration (FDA) has unveiled a new programme that will reduce its review time for certain drug ...

AstraZeneca (AZ) has announced promising results from a late-stage study of its C5 complement inhibitor Ultomiris ...

For years, women have been significantly underrepresented in clinical trials, despite making up a large portion of patients ...

In 2025, data protection is more important than ever. Yet, many in the pharma industry are still behind when it comes to ...